INSIGHTS FROM RENAL BIOPSY DATA REGISTRY IN AFRICA AND MIDDLE EAST: A SINGLE-CENTER EXPERIENCE

 

Certificate Output Instructions

For best output, select "Paper Size" as "A4" and "Margin" as "0" or "None".

To save or print to PDF, please select Print Destination > Save as PDF, enable Background Graphics under "More Settings", then click "Save".

 


 

Certificate Background

   

Presented the abstract " "
(Abstract co-author(s):  )

 

 

E-Poster Presentation

During the congress, E-Posters will be accessible to all participants on the congress website 24/7, as well as in the E-poster stations in the congress center. 

Preparing your E-Poster

Please review the E-Poster format requirements carefully when preparing your E-Poster. Should your E-Poster not meet the mentioned requirements, it may not be displayed as described above.

​E-Poster Submission Deadline

Please prepare and upload your E-Poster no later than March 14, 2026 11.59PM CET. After this date, you will no longer be able to prepare and upload your E-poster and it will not be displayed and accessible on the congress website.​

E-Poster Format Requirements
  • PDF file
  • Layout: Portrait (vertical orientation)
  • One page only (Dim A4: 210 x 297mm or PPT)
  • E-Poster can be prepared in PowerPoint (one (1) PowerPoint slide) but must be saved and submitted as PDF file.
  • File Size: Maximum file size is 2 Megabytes (2 MB)
  • No hyperlinks, animated images, animations, and slide transitions
  • Language: English
  • Include your abstract number
  • E-posters can include QR codes, tables and photos
https://storage.unitedwebnetwork.com/files/1099/c06c158922e4627932b42d888ff2b372.pdf
INSIGHTS FROM RENAL BIOPSY DATA REGISTRY IN AFRICA AND MIDDLE EAST: A SINGLE-CENTER EXPERIENCE

Please follow the instructions below to input your abstract title.

Abstract titles should be brief and reflect the content of the abstract.

  • The title will not be accepted if it exceeds 25 words.
  • Type in CAPITAL LETTERS.
  • Lowercase may be used for abbreviations only, for example, mRNA.
Mohamed
Abdalbary
Mohamed Abdalbary dr.mo7a.m@mans.edu.eg Mansoura University Internal Medicine Department Mansoura Egypt *
Alaa A. Elsawi alaaabdelnasser@mans.edu.eg Mansoura University Internal Medicine Department Mansoura Egypt -
Rabab Elrefaey Rababelrefaey@mans.edu.eg Mansoura University Internal Medicine Department Mansoura Egypt -
Shimaa Shabaka shimashabaka@mans.edu.eg Mansoura University Internal Medicine Department Mansoura Egypt -
Mostafa Abdelsalam Darsh1980@mans.edu.eg Mansoura University Internal Medicine Department Mansoura Egypt -
Alaa Sabry asabry2040@mans.edu.eg Mansoura University Internal Medicine Department Mansoura Egypt -
Ekbal Elkhouli ikbalelkholy@mans.edu.eg Mansoura University Pathology Department Mansoura Egypt -
Dina A. Ibrahim Dina.abdallah@mans.edu.eg Mansoura University Pathology Department Mansoura Egypt -
Ahmed Almenshawy menshawyahmad@mans.edu.eg Mansoura University Clinical Pathology Department Mansoura Egypt -
Eman Nagy emannagy@mans.edu.eg Mansoura University Internal Medicine Department Mansoura Egypt -
-
-
-
-
-

Renal biopsy remains the gold standard for diagnosing kidney diseases, particularly glomerular disorders. Histopathological examination provides critical insights into disease pathogenesis, assessment of activity and chronicity, clinical decision-making, and prognostic evaluation. Data registries are essential tools for understanding the epidemiology, clinical features, and outcomes of renal disorders, thereby improving clinical practice and informing health policy. However, comprehensive renal biopsy registries are currently lacking in Africa and Middle East. This study aimed to establish an organized repository of renal biopsy data to enhance understanding of the nature and prognosis of glomerulonephritis and correlate histopathological findings with clinical and laboratory parameters in patients undergoing renal biopsy at the Mansoura Nephrology and Dialysis Unit (MNDU), a tertiary referral center in Egypt.

We conducted a prospective observational registry of all patients undergoing native or transplant renal biopsies at MNDU over one year (July 2024 to July 2025). Indications for biopsy comprised unexplained acute kidney injury (AKI), as well as suspected glomerular, tubulointerstitial, or vascular kidney diseases. All procedures were performed by experienced nephrologists using real-time ultrasound guidance, and biopsy specimens were interpreted by dedicated nephropathologists at Mansoura University.

Patient Demographics and Biopsy Safety

A total of 304 renal biopsies were performed during the study period. The cohort comprised 189 females (62.2%) and 115 males (37.8%). Patients were referred from 13 of Egypt's 27 governorates, predominantly from Dakahlia, Gharbia, Sharqia, Damietta, and Beheira. Native kidney biopsies accounted for 291 cases, with 13 transplant kidney biopsies.

The procedure demonstrated excellent safety, with complication rates remaining very low. Only 0.7% (n=2) required blood transfusion due to large hematomas, and all complications were self-limited without requiring surgical or radiological intervention. Most biopsies yielded adequate tissue for diagnosis, with a mean glomerular count of 22±12; only 5 biopsies were considered limited.

Clinical Characteristics and Indications

Common comorbidities included hypertension (42.4%, n=129), diabetes mellitus (11.2%, n=34), hepatitis C virus seropositivity (6.6%, n=20), and family history of kidney disease (3.3%, n=10). The median eGFR at presentation was 32.7 mL/min/1.73m² (IQR: 9.38–80.88).

The primary indications for biopsy were isolated proteinuria (33.2%, n=101) and unexplained renal impairment combined with proteinuria (31.6%, n=96). Isolated unexplained renal impairment accounted for 27.0% (n=82) of cases. Less frequent indications included rapidly progressive glomerulonephritis (RPGN) (3.3%, n=10), the triad of renal impairment, proteinuria, and hematuria (1.6%, n=5), isolated hematuria (1.6%, n=5), and combined proteinuria and hematuria without renal impairment (1.3%, n=4).

Histopathological Spectrum

Lupus nephritis (LN) was the most common diagnosis, representing 28.8% of cases, with Class IV predominating (73%) over Class III (27%). The second most frequent diagnosis was membranoproliferative glomerulonephritis (MPGN) (17.6%), followed by diffuse glomerulosclerosis (13.6%), focal segmental glomerulosclerosis (FSGS) (11.2%), tubulointerstitial nephritis (TIN) (7.0%), mesangial proliferative GN (6.4%), membranous nephropathy (4.8%), crescentic GN (4.0%), and minimal change disease (MCD) (2.4%).

Among diabetic patients, 70% had diabetic nephropathy on biopsy, while 30% had other glomerulonephritides, primarily MPGN and LN. Gender distribution varied by diagnosis: LN demonstrated marked female predominance (female-to-male ratio 4.8:1), MPGN showed equitable gender distribution (~1:1), and MCD, FSGS, and membranous nephropathy were more common in males.

Clinicopathological Correlations

Sonographic Assessment: Pre-biopsy sonographic evaluation by nephrologists revealed statistically significant correlations with histopathological markers of chronicity. The echogenicity index demonstrated strong positive correlations with interstitial fibrosis percent (r=0.498, p<0.001), tubular atrophy percent (r=0.468, p<0.001), and total percent of glomerulosclerosis (r=0.412, p<0.001). Additionally, echogenicity correlated with vascular changes (r=0.273, p=0.002), often indicating arteriolar hyalinosis or hypertensive vascular changes.

Kidney Function: eGFR and serum creatinine at presentation exhibited the strongest correlations with chronic damage parameters, including tubular atrophy percent (r=-0.565/0.561, p<0.001), interstitial fibrosis percent (r=-0.616/0.612, p<0.001), and glomerulosclerosis percent (r=-0.358/0.364, p<0.001).

Proteinuria: Neither quantitative proteinuria nor dipstick analysis correlated with chronic damage scores (interstitial fibrosis and tubular atrophy [IFTA], glomerulosclerosis). However, quantitative proteinuria showed a positive correlation with detached podocytes (r=0.670, p=0.024).

Hematuria: Most patients (63.3%) exhibited mild hematuria (<20 RBCs/hpf), while 13.5% had significant hematuria (>50 RBCs/hpf). Hematuria correlated specifically with active inflammatory lesions, particularly crescent formation (r=0.218, p=0.022), but not with chronic damage markers.

Hypertension and Age: Both hypertension and advancing age demonstrated significant associations with chronic sclerotic damage—including tubular atrophy, interstitial fibrosis, global glomerulosclerosis, and vascular changes—rather than active inflammatory lesions. Older patients showed higher prevalence of diabetic nephropathy and hypertensive nephrosclerosis (p=0.018).

Hepatitis C Virus: HCV-positive patients demonstrated increased likelihood of MPGN (p=0.009) and cryoglobulinemic features.

Renal biopsy is a safe procedure that provides crucial diagnostic information. In our Egyptian cohort, lupus nephritis emerged as the most prevalent glomerular disease, predominantly affecting females. Sonographic echogenicity index, kidney function at presentation, hypertension, and advancing age were strongly associated with chronic histological damage, whereas proteinuria showed no such correlation. Hematuria was specifically linked to active inflammatory lesions, particularly presence of crescents. These findings underscore the diagnostic and prognostic value of renal biopsy in understanding disease mechanisms and guiding management in our population.

Kewords